NOVEL INTERACTION BETWEEN PROTEINS, THERAPEUTIC AGENT FOR DISUSE ATROPHY UTILIZING THE NOVEL INTERACTION, AND METHOD RELATING TO DISUSE ATROPHY

摘要

[PROBLEMS] To provide novel interactions between proteins. [MEANS FOR SOLVING PROBLEMS] A protein interaction between proteasome and ZNF216 (or AWP1) has been found. Also, a protein interaction between polyubiquitin chain and ZNF216 (or AWP1) has been found. Utilizing these novel protein interactions, there are provided a therapeutic agent for disuse atrophy, method of screening a therapeutic agent for disuse atrophy, marker for disease diagnosis, method of onset risk estimation, etc.